Half-year report · Q2
3001.TEDINET S100U71O
Period2024-01-01 → 2024-06-30
Filed2024-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥19.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥40.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.1bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.7bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.7bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥2.1bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥138.6bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥139.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥141.8bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥48.6bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥50.2bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥90.0bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥89.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥89.8bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥28.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥29.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.8bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.5bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥606m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥5m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.0bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥55.76 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.91 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.79 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 55.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥186m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | ¥94m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥202m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥202m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥590m |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.4bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.4bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥0 |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥6.1bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥6.1bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥33m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥14m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1m |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥364m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥19.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥19.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥202m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥2.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-06-30 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥183m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | ¥107m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥199m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥199m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥576m |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| jpcrp040300-q2r_E00524-000Machinery Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥185m |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥6.3bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥6.3bn |
| jpcrp040300-q2r_E00524-000Pharmaceuticals Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥197m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥5.4bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥5.3bn |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥14m |
| jpcrp040300-q2r_E00524-000Real Estate Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥2.2bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥0 |
| jpcrp040300-q2r_E00524-000Textiles Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥425m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥20.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥20.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥199m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥2.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 565
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding special retirement expenses (text) | Prior1YTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |